Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies 

Chair: Meena Bansal (USA)

18:45 – 18:55Introduction. The Growing Burden of MASLD/MASH: A Call to ActionMeena Bansal (USA)
18:55 – 19:10THR-β Agonists and Other Disease-specific Therapies Poised to Change the ParadigmElisabetta Bugianesi (ITA)
19:10 – 19:20Rising to the Need to Improve Diagnosis in the Era of Disease-specific Therapy 
19:20 – 19:40Clinical Case Challenge: Integrating MASLD/MASH-Specific Therapy into PracticeMeena Bansal (USA)
19:40 – 19:45Q&AAll faculty

This activity is jointly provided by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC.

This activity is supported by an educational grant from Madrigal Pharmaceuticals.